SCHEMBL4122825

SCHEMBL4122825

Cc1c(C(O)CNC(C)(C)C)ccc(O)c1O

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 4/20 0.50
HIF1A Q16665 4/20 0.50
ADRB1 P08588 3/20 0.50
CYP2D6 P10635 2/20 0.50
NFKB1 P19838 2/20 0.50
TSHR P16473 2/20 0.49
CYP1A2 P05177 1/20 0.49
BLM P54132 1/20 0.49
LMNA P02545 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
ADRA2A P08913 1/20 0.46
ADRA2B P18089 1/20 0.46
ADRA2C P18825 1/20 0.46
ADRA1A P35348 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CASP7 P55210 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11841871 0.83 ADRB2 (0.56) ADRB2HIF1AADRB1CYP2D6NFKB1
SCHEMBL9767993 0.81 ADRA2A (0.68) ADRB2HIF1AADRB1CYP2D6TSHR
SCHEMBL1461292 0.81 ADRA2A (0.68) ADRB2HIF1AADRB1CYP2D6TSHR
SCHEMBL11692760 0.81 ADRB2 (0.58) ADRB2ADRB1
SCHEMBL11691981 0.81 ADRB2 (0.55) ADRB2ADRB1
SCHEMBL29278698 0.80 ADRA2A (0.66) ADRB2HIF1AADRB1CYP2D6TSHR
SCHEMBL5894120 0.79 ADRB2 (0.61) ADRB2ADRB1
SCHEMBL5893893 0.79 ADRB2 (0.42) ADRB2ADRB1ADRA2AADRA2BADRA2C
SCHEMBL5894212 0.79 ADRB2 (0.42) ADRB2ADRB1ADRA2AADRA2BADRA2C
SCHEMBL4869389 0.76 ADRB2 (0.48) ADRB2ADRB1CYP2D6CYP1A2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090047336-A1 NOVEL FORMULATION OF DEHYDRATED LIPID VESICLES FOR CONTROLLED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT VIA INHALATION HONG KONG BAPTIST UNIVERSITY (CN) 2009-02-19 US disclosed